The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.
Open accessAbstract
We have developed a method to isolate insulin-responsive human hepatocytes from an intraoperative liver biopsy to study insulin action and resistance in man.Hepatocytes from obese patients with noninsulin-dependent diabetes were resistant to maximal insulin concentration, and those from obese controls to submax- imal insulin concentration in comparison to nonobese controls.Insulin binding per cell number was similar in all groups.How- ever, insulin binding per surface area was decreased in the two obese groups because their hepatocytes were larger.In addition, the pool of detergent-extractable receptor was further decreased in diabetics.Insulin receptors in all groups were unaltered as determined by affinity-labeling methods.However, insulin-stim- ulated insulin receptor kinase activity was decreased in diabetics.Thus, in obesity, decreased surface binding could explain re- sistance to submaximal insulin concentrations.In diabetes, di- minished insulin-stimulated protein kinase activity and decreased intracellular pool of receptors could provide an explanation for postinsulin-binding defect(s) of insulin action in human liver. Methods Materials. a-[ I 14C]Aminoisobutyric acid (51.6 mCi/mmol), carrier-freeNa 125I, [methoxyl-3H]inulin (186.4 mCi/g), 3-0-['4C] methyl-D-glucose (58.0 mCi/mmol), L-[U-_4C]leucine (300 mCi/mmol), and [I-_4C]acetic acid, sodium salt (56.0 mCi/mmol) were obtained from New England Nuclear, Boston, MA.Crude collagenase (type IV, lots 124F-6807, 25F-6806, 25F-68 17, 44F-68 12) and deoxyribonuclease were obtained from Sigma Chemical Co., St. Louis, MO; dispase was purchased from Boeh- ringer Mannheim Biochemicals, Indianapolis, IN; and soybean trypsin inhibitor from Worthington Biomedical Corp., Freehold, NJ.Fraction V bovine serum albumin (BSA) was obtained from Armour Pharma- ceutical, Co., Kankakee, IL, and it was further purified by charcoal treat- ment (23).Crystalline porcine insulin was kindly provided by Dr. Ronald Chance of Eli Lilly & Co., Indianapolis, IN.All other chemicals were reagent grade.Human subjects.11 morbidly obese patients with NIDDM and an equal number of morbidly obese patients without diabetes were studied.The clinical and biochemical data ofthese patients are presented in Table I.These patients were admitted to the hospital to undergo gastric bypass for the treatment of morbid obesity.We also studied a nonobese non- diabetic group composed of four subjects who had uncomplicated gallstone disease and were admitted for elective cholecystectomy, and five brain-dead organ donors.The biochemical data on the liver ofthese two clinically different subgroups of nonobese subjects were identical.Thus, they have been combined and referred to as the nonobese comparison group.The value ofthe organ donor's liver should be underscored because we have the entire liver from the donors.This tissue has been fundamentalInsulin Resistance in Liverfrom Noninsulin-dependent Diabetes 249
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies have demonstrated a modest 20–30% reduction in insulin binding to monocytes and adipocytes from type 2 diabetic patients, but this has not been a consistent finding [1, 151–154].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [153]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [153]
In the citing paper
“insulin binding to solubilized receptors obtained from skeletal muscle and liver has been shown to be normal in obese and lean diabetic individuals [152, 153, 155].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
Defronzo, R., Deibert, D., Hendler, R., Felig, P., & Soman, V. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109394 · Cited by 188
RetractedCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,191
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Removal of Fatty Acids from Serum Albumin by Charcoal Treatment
Chen, R. F. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81445-x · Cited by 2,093
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Insulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,132
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system
Kasuga, M., Zick, Y., Blithe, D., Crettaz, M., & Kahn, C. R. (1982) · Nature · doi:10.1038/298667a0 · Cited by 680
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 714
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488
The insulin receptor and the molecular mechanism of insulin action.
Kahn, C. R., & White, M. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113711 · Cited by 432
Folli, F. B., Kahn, C. R., Hansen, H. F., Bouchie, J. L., & Feener, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119752 · Cited by 421
Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitus
Kissebah, A. H., & Peiris, A. N. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050202 · Cited by 384
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Caro, J. F., Sinha, M. K., Raju, S. M., Ittoop, O., Pories, W. J., Flickinger, E. G., Meelheim, D., & Dohm, G. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112958 · Cited by 341
Self-citationLipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 326
Fantus, I. G., Kadota, S., Deragon, G., Foster, B. A., & Posner, B. I. (1989) · Biochemistry · doi:10.1021/bi00448a027 · Cited by 314
Serine/Threonine Phosphorylation of IRS-1 Triggers Its Degradation
Pederson, T. M., Kramer, D. L., & Rondinone, C. M. (2001) · Diabetes · doi:10.2337/diabetes.50.1.24 · Cited by 298
Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S., Elton, C. W., & Caro, J. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113622 · Cited by 296
Self-citationPathophysiology of insulin resistance
Sesti, G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.007 · Cited by 297
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction
Byon, J. C. H., Kusari, A. B., & Kusari, J. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006868409841 · Cited by 271
Folli, F. B., Saad, M. J. A., Backer, J., & Kahn, C. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41650-x · Cited by 251
Caro, J. F., Poulos, J., Ittoop, O. R. R., Pories, W. J., Flickinger, E. G., & Sinha, M. K. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113451 · Cited by 249
Self-citationInsulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
Petersen, M. C., Madiraju, A. K., Gassaway, B. M., Marcel, M., Nasiri, A. R., Butrico, G. M., Marcucci, M., Zhang, D., Abulizi, A., Zhang, X., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86013 · Cited by 260
Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins
Yamanaka, Y., Wilson, E., Rosenfeld, R. G., & Oh, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30729 · Cited by 225
Folli, F. B., Saad, M. J. A., Backer, J., & Kahn, C. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116768 · Cited by 220
Low Urinarychiro-Inositol Excretion in Non-Insulin-Dependent Diabetes Mellitus
Kennington, A. S., Hill, C. R., Craig, J. W., Bogardus, C., Raz, I., Ortmeyer, H. K., HANSEN, B. C., Romero, G. G., & Larner, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008093230603 · Cited by 218
PTP1B and TCPTP – nonredundant phosphatases in insulin signaling and glucose homeostasis
Tiganis, T. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08563.x · Cited by 209
Freidenberg, G. R., Reichart, D. R., Olefsky, J. M., & Henry, R. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113744 · Cited by 196
Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?
Pories, W. J., MacDonald, K. G., Flickinger, E. G., Dohm, G. L., Sinha, M. K., Barakat, H. A., May, H. J., Khazanie, P. G., Swanson, M. S., MORGAN, E., et al. (1992) · Annals of Surgery · doi:10.1097/00000658-199206000-00010 · Cited by 191
Self-citationHuman Diabetes Associated with a Mutation in the Tyrosine Kinase Domain of the Insulin Receptor
Odawara, M., Kadowaki, T., Yamamoto, R., Shibasaki, Y., Tobe, K., Accili, D., Bevins, C. L., Mikami, Y., Matsuura, N., Akanuma, Y., et al. (1989) · Science · doi:10.1126/science.2544998 · Cited by 189
The Control of Diabetes Mellitus (NIDDM) in the Morbidly Obese with the Greenville Gastric Bypass
Pories, W. J., CARD, J. F., Flickinger, E. G., MEELHEIM, H. D., & Swanson, M. S. (1987) · Annals of Surgery · doi:10.1097/00000658-198709000-00009 · Cited by 185
Self-citationArner, P., Pollare, T., Lithell, H., & Livingston, J. N. (1987) · Diabetologia · doi:10.1007/bf00292549 · Cited by 178
Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats
Su�rez, A., Pulido, N., Casla, A., Casanova, B., Arrieta, F., & Rovira, A. (1995) · Diabetologia · doi:10.1007/bf00401757 · Cited by 175
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
Lyu, K., Zhang, Y., Zhang, D., Kahn, M., ter Horst, K. W., Rodrigues, M. R. D. S., Gaspar, R. C., Hirabara, S. M., Luukkonen, P. K., Lee, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.001 · Cited by 173
Dietary Zinc Supplementation Attenuates Hyperglycemia in db/db Mice
Simon, S. F., & Taylor, C. G. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600107 · Cited by 170
Caro, J. F., Dohm, L. G., Pories, W. J., & Sinha, M. K. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050804 · Cited by 165
Self-citationTaylor, R., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2500625 · Cited by 166
Moller, D. E., & Flier, J. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192306 · Cited by 154
In vivo andin vitro studies of vanadate in human and rodent diabetes mellitus
Goldfine, A. B., Simonson, D. C., Folli, F. B., Patti, M., & Kahn, C. R. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01075941 · Cited by 146
Considine, R. V., Nyce, M. R., Allen, L. E., Morales, L. M., Triester, S., Serrano, J., Colberg, J., Lanza-Jacoby, S., & Caro, J. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118001 · Cited by 141
Self-citationThe Insulin Receptor - A Critical Link in Glucose Homeostasis and Insulin Action
Patti, M., & Kahn, C. R. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.89 · Cited by 138
Insulin receptor endocytosis in the pathophysiology of insulin resistance
Hall, C., Yu, H., & Choi, E. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0456-3 · Cited by 149
H�ring, H. U. (1991) · Diabetologia · doi:10.1007/bf00400192 · Cited by 133
Federico, L. M., Naples, M., Taylor, D., & Adeli, K. (2006) · Diabetes · doi:10.2337/db04-1084 · Cited by 132
Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms
Olefsky, J. M., & Nolan, J. J. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.980s · Cited by 124
Kusari, J., Kenner, K. A., Suh, K. I., HILL, D. E., & Henry, R. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117068 · Cited by 123
The kinetics of insulin in man. II. Role of the liver
Ferrannini, E., & Cobelli, C. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030202 · Cited by 114
Draznin, B., LEWIS, D., Houlder, N., SHERMAN, N., Adamo, M. L., Garvey, W. T., LeRoith, D., & Sussman, K. E. (1989) · Endocrinology · doi:10.1210/endo-125-5-2341 · Cited by 115
Comi, R. J., Grunberger, G., & Görden, P. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112833 · Cited by 112
Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations
Rossetti, L., DeFronzo, R. A., Gherzi, R., Stein, P., Andraghetti, G., Falzetti, G., Shulman, G. I., Klein-Robbenhaar, E., & Cordera, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90259-f · Cited by 111
Mosthaf, L., Vogt, B., Häring, H., & Ullrich, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4728 · Cited by 110
Nolan, J. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.471 · Cited by 108
Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch, J., Backer, J., & Kahn, C. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114261 · Cited by 104
Qin, B., Qiu, W., Avramoglu, R. K., & Adeli, K. (2007) · Diabetes · doi:10.2337/db06-0518 · Cited by 103
Firth, R. G., Bell, P. M., & Rizza, R. A. (1987) · Metabolism · doi:10.1016/0026-0495(87)90031-x · Cited by 102
Hari, J., & Roth, R. A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47729-0 · Cited by 97
Avramoglu, R. K., Theriault, A., & Adeli, K. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00038-9 · Cited by 96
The Insulin Receptor and Its Substrate: Molecular Determinants of Early Events in Insulin Action
Kahn, C. R., White, M. F., Shoelson, S. E., Backer, J., Araki, E., Cheatham, B., Csermely, P., Folli, F. B., Goldstein, B. J., Huertas, P. E., et al. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50015-4 · Cited by 91
Kusari, J., Verma, U. S., Buse, J. B., Henry, R. R., & Olefsky, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115437 · Cited by 90
The Insulin Receptor: Structure and Functio
Zick, Y. (1989) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238909082554 · Cited by 89
Choi, E., Kikuchi, S., Gao, H., Brodzik, K., Nassour, I., Yopp, A., Singal, A. G., Zhu, H., & Yu, H. (2019) · Nature Communications · doi:10.1038/s41467-019-09318-3 · Cited by 89
Friedman, J. E., Dohm, G. L., Elton, C. W., Rovira, A., Chen, J. J., Leggett-Frazier, N., Atkinson, S., Thomas, F., Long, S. D., & Caro, J. F. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e87 · Cited by 88
Self-citationKanety, H., Moshe, S., Shafrir, E., Lunenfeld, B., & Karasik, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1853 · Cited by 87
Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes
Olefsky, J. M., Garvey, W. T., Henry, R. R., Brillon, D. J., Matthael, S., & Freidenberg, G. R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90401-9 · Cited by 85
Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes
Cook, J. R., Langlet, F., Kido, Y., & Accili, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638197 · Cited by 83
The Activation Mechanism of the Insulin Receptor: A Structural Perspective
Choi, E., & Bai, X. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-033250 · Cited by 87
Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat
Friedman, J. E., Ishizuka, T., Liu, S., Farrell, C. J., Bedol, D., Koletsky, R. J., Kaung, H. C., & Ernsberger, P. R. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e1014 · Cited by 81
Insulin receptor internalization: molecular mechanisms and physiopathological implications
Carpentier, J. L. (1994) · Diabetologia · doi:10.1007/bf00400835 · Cited by 80
Karasik, A., Rothenberg, P., Yamada, K. D., White, M. F., & Kahn, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86935-6 · Cited by 80
Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Abdul‐Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Suwaidi, J. M. S. A. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666171010115119 · Cited by 79
Dadke, S. S., Li, H. C., Kusari, A. B., Begum, N., & Kusari, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3188 · Cited by 76
Activation of Protein Kinase Cα Inhibits Signaling by Members of the Insulin Receptor Family
Danielsen, A. G., Liu, F., Hosomi, Y., Shii, K., & Roth, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21600 · Cited by 71
Adeli, K. (2003) · Frontiers in bioscience · doi:10.2741/1022 · Cited by 70
1 Cellular insulin action and insulin resistance
Garvey, W. T., & Birnbaum, M. J. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80237-x · Cited by 67
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice
Buettner, C., Patel, R. D., Muse, E. D., Bhanot, S., Monia, B. P., McKay, R., Obici, S., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23109 · Cited by 69
Qureshi, S. A., Ding, V. D. H., Li, Z., Szalkowski, D., Biazzo-Ashnault, D. E., Xie, D., Saperstein, R., Brady, E. J., Huskey, S.-E. W., Shen, X., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006287200 · Cited by 68
Giorgino, F., Chen, J. H., & Smith, R. J. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531627 · Cited by 66
β Cell function and plasma insulin clearance in people with obesity and different glycemic status
Mittendorfer, B., Patterson, B. W., Smith, G. I., Yoshino, M., & Klein, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci154068 · Cited by 73
Qin, B., Anderson, R. A., & Adeli, K. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2007 · Cited by 65
Pugazhenthi, S., Angel, J. F., & Khandelwal, R. L. (1991) · Metabolism · doi:10.1016/0026-0495(91)90070-d · Cited by 65
The UPS in diabetes and obesity
Wing, S. S. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s6 · Cited by 67
Cecchin, F., Ittoop, O. R. R., Sinha, M. K., & Caro, J. F. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.4.e394 · Cited by 62
Self-citationH�ring, H. U., & Mehnert, H. (1993) · Diabetologia · doi:10.1007/bf00399946 · Cited by 60
O’Brien, R. M., Soos, M. A., & Siddle, K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02743.x · Cited by 60
Protein kinase C: Mediator or inhibitor of insulin action?
Considine, R. V., & Caro, J. F. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240520103 · Cited by 57
Self-citationInsulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans
Nyomba, B. L. G., Ossowski, V., Bogardus, C., & Mott, D. M. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.6.e964 · Cited by 55
Exercise Training in Obese Diabetic Patients
Zierath, J. R., & Wallberg‐Henriksson, H. (1992) · Sports Medicine · doi:10.2165/00007256-199214030-00004 · Cited by 51
Insulin Receptor Structure And Function In Normal And Pathological Conditions
Becker, A. B., & Roth, R. A. (1990) · Annual Review of Medicine · doi:10.1146/annurev.me.41.020190.000531 · Cited by 52
Lebron, B. A., PEKARY, A. E., Mirell, C. J., Hahn, T. J., & Hershman, J. M. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040207 · Cited by 50
Kusari, J., Takata, Y., Hatada, E. N., Freidenberg, G. R., Kolterman, O., & Olefsky, J. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67781-1 · Cited by 50
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa, G., Bhatia, R., Dhindsa, M., & Bhatia, V. (2004) · PubMed · Cited by 48
Block, N. E., & Buse, M. G. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.1.e39 · Cited by 45
Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes
Salhanick, A. I., Schwartz, S. I., & Amatruda, J. M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90109-a · Cited by 44
Insulin Clearance in Obesity and Type 2 Diabetes
Koh, H. E., Cao, C., & Mittendorfer, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020596 · Cited by 52
The journey of the insulin receptor into the cell: from cellular biology to pathophysiology
Carpentier, J. (1993) · Histochemistry and Cell Biology · doi:10.1007/bf00269090 · Cited by 39
Insulin resistance versus insulin secretion in the hypertension of obesity.
Istfan, N. W., PLAISTED, C. S., Bistrian, B. R., & Blackburn, G. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.4.385 · Cited by 41
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 39
Melin, B., Cherqui, G., Eggelpoël, M.-J. B.-V., Caron, M., Lascols, O., Capeau, J., & Picard, J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90171-8 · Cited by 38
Thakker, J. K., DiMarchi, R. D., MacDonald, K. G., & Caro, J. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83217-3 · Cited by 37
Self-citationEffects of glyburide on carbohydrate metabolism and insulin action in the liver
Caro, J. F. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90332-8 · Cited by 36
Self-citationGruppuso, P. A., Boylan, J. M., Posner, B. I., Faure, R. L., & Brautigan, D. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114632 · Cited by 34
Metadata
- Authors
- Caro, J. F., Ittoop, O., Pories, W. J., Meelheim, D., Flickinger, E. G., Thomas, F., Jenquin, M., Silverman, J. F., Khazanie, P. G., & Sinha, M. K.
- Affiliations
- East Carolina University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1986-07-01
- Volume
- 78
- Issue
- 1
- Pages
- 249-258
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC329556
- OpenAlex
- W2062299625
- Cited by
- 215
- References
- 74
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 5 · 2013: 1 · 2012: 2
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-AM3285-04)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- insulin resistance, type 2 diabetes, liver, hepatocytes, insulin receptor, insulin receptor kinase, insulin binding, obesity, insulin action, receptor internalization, insulin-stimulated glucose transport
- MeSH terms
- Biopsy, Cell Separation, Diabetes Mellitus, Electrophoresis, Polyacrylamide Gel, Humans, Insulin, Insulin Resistance, Kinetics, Liver, Obesity, Protein Kinases, Receptor, Insulin, Structure-Activity Relationship
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review